Christine Poon
American business executive
Christine Ann Poon (born c. 1952 in Brentwood, Missouri) is an American business executive.2
From Wikipedia’s article on Christine Poon (this version), CC BY-SA 4.0.
Born 1952.1
About
She is the former vice chairman of the Johnson & Johnson Board of Directors and worldwide chairman of J&J's Pharmaceuticals Group.
From Wikipedia’s article on Christine Poon, shared under CC BY-SA 4.0.2
Companies
- Neurocrine BiosciencesBoard member Jul 13, 2023 to now9
- Sherwin-WilliamsBoard member Apr 16, 2014 to now10
- Regeneron PharmaceuticalsBoard member Nov 15, 2010 to now11
- Prudential FinancialBoard member Sep 2006 to now12
- Decibel Therapeutics, Inc.Board member Feb 11, 2021 to Feb 16, 202113
- Johnson & JohnsonBoard member Jan 4, 2006 to Feb 17, 200914
- Johnson & JohnsonVice chair Jan 4, 2006 to Feb 17, 200914
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Sherwin-Williams SHW14,959 shares15$5.0M at $334.56Apr 7, 2025
Regeneron Pharmaceuticals REGN5,219 shares16$4.1M at $790.61Jan 2, 2026
Prudential Financial PRU11,583 shares17$1.3M at $115.78May 12, 2026
Neurocrine Biosciences NBIX4,753 shares18$652.9K at $137.36May 21, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 21, 2026Exercised options 3,318 shares of Neurocrine Biosciences18
- May 12, 2026Returned to company 1,765 shares at $102.58 of Prudential Financial17
- May 12, 2026Exercised options 1,765 shares of Prudential Financial17
- Jan 2, 2026Granted 155 shares of Regeneron Pharmaceuticals16
- Oct 30, 2025Exercised options 2,712 shares at $520.01 of Regeneron Pharmaceuticals19
- Oct 29, 2025Sold 388 shares at $657.29 of Regeneron Pharmaceuticals19
- Oct 29, 2025Sold 712 shares at $656.50 of Regeneron Pharmaceuticals19
- Oct 29, 2025Sold 100 shares at $655.10 of Regeneron Pharmaceuticals19
- Oct 29, 2025Sold 1,915 shares at $654.42 of Regeneron Pharmaceuticals19
- Oct 29, 2025Sold 2,735 shares at $653.50 of Regeneron Pharmaceuticals19
- Oct 29, 2025Sold 650 shares at $652.68 of Regeneron Pharmaceuticals19
- Oct 29, 2025Exercised options 6,500 shares at $520.01 of Regeneron Pharmaceuticals19
- May 22, 2025Exercised options 1,435 shares of Neurocrine Biosciences20
- May 13, 2025Returned to company 1,321 shares at $107.40 of Prudential Financial21
- May 13, 2025Exercised options 1,321 shares of Prudential Financial21
- Apr 4, 2025Granted 4 shares at $338.25 of Sherwin-Williams15
- Feb 18, 2025Granted 517 shares of Sherwin-Williams22
- Jan 3, 2025Granted 25 shares at $335.00 of Sherwin-Williams23
- Jan 2, 2025Granted 166 shares of Regeneron Pharmaceuticals24
- Dec 20, 2024Inherited 14 shares of Regeneron Pharmaceuticals24
- Oct 4, 2024Granted 23 shares at $372.47 of Sherwin-Williams25
- Aug 15, 2024Sold 100 shares at $1,161.32 of Regeneron Pharmaceuticals26
- Aug 15, 2024Sold 234 shares at $1,160.45 of Regeneron Pharmaceuticals26
- Aug 15, 2024Sold 5,352 shares at $1,159.56 of Regeneron Pharmaceuticals26
- Aug 15, 2024Sold 212 shares at $1,158.02 of Regeneron Pharmaceuticals26
Early life and education
- Date not recordedNorthwestern University3
- Date not recordedQuestrom School of Business3
- Date not recordedSaint Louis University3
- Date not recordedBoston University3
Poon was raised as one of seven children; her mother was a nurse, and her father a physician. In a 2013 Distinguished Lecture at West Virginia University, she related how early experiences being Chinese in a predominantly white Ohio suburb shaped her character and desire to "...not be the stereotype you saw, but be who I wanted to be." Poon credits her brother for encouraging her to pursue a career at the interface of science and business, which led to her enrollment for an MBA (1982) and eventual employment at BMS in the Strategic Planning function.
From Wikipedia’s article on Christine Poon (this version), CC BY-SA 4.0.
Career
Occupation: university teacher, entrepreneur.6
- Since 2006Board member, Prudential Financial5
- Date not recordedWorked at Ohio University4
Poon worked at Bristol Myers Squibb from 1985 to 2000, advancing to the position of President of the international medicines division. She credited an early role transition from a "line" to a "staff" function - Global Marketing - which exposed her to a more international vision of the pharmaceutical world and prepared her for leadership. She then joined Johnson & Johnson for 8 years, from 2000 to 2008. Major projects during her time included drugs to treat pain, schizophrenia, and HIV.
After her stint with J&J, Poon served as dean of Ohio State University's Fisher College of Business from April 2009 to November 2014. She is also member of the board of directors of Prudential Financial, Regeneron Pharmaceuticals, and Sherwin-Williams, and member of the supervisory board of Royal Philips Electronics.
From Wikipedia’s article on Christine Poon (this version), CC BY-SA 4.0.
Personal life
Links
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataChristine Poon on Wikidata
- 2WikipediaChristine Poon on Wikipedia
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARNeurocrine Biosciences, Board member
- 10SEC EDGARSherwin-Williams, Board member
- 11
- 12Wikidata and SEC EDGARPrudential Financial, Board member
- 13
- 14SEC EDGARJohnson & Johnson, Board member
- 15
- 16
- 17
- 18
- 19SEC EDGARForm 4 filed Oct 31, 2025
- 20SEC EDGARForm 4 filed May 22, 2025
- 21SEC EDGARForm 4 filed May 15, 2025
- 22SEC EDGARForm 4 filed Feb 20, 2025
- 23SEC EDGARForm 4 filed Jan 7, 2025
- 24SEC EDGARForm 4 filed Jan 6, 2025
- 25SEC EDGARForm 4 filed Oct 8, 2024
- 26SEC EDGARForm 4 filed Aug 19, 2024